vs
Atkore Inc.（ATKR）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是Atkore Inc.的1.2倍（$772.1M vs $655.5M），Revvity净利率更高（12.7% vs 2.3%，领先10.4%），Revvity同比增速更快（5.9% vs -0.9%），Revvity自由现金流更多（$161.8M vs $-67.3M），过去两年Revvity的营收复合增速更高（9.0% vs -9.1%）
Atkore Inc.是领先的电气、安全及基础设施产品制造商，主营钢与PVC导管、线缆管理系统、结构框架解决方案及消防安全设备，主要服务建筑、工业、公用事业、通信领域，核心市场覆盖北美，同时在全球多地开展业务。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
ATKR vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.2倍
$655.5M
营收增速更快
RVTY
高出6.8%
-0.9%
净利率更高
RVTY
高出10.4%
2.3%
自由现金流更多
RVTY
多$229.0M
$-67.3M
两年增速更快
RVTY
近两年复合增速
-9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $655.5M | $772.1M |
| 净利润 | $15.0M | $98.4M |
| 毛利率 | 19.2% | — |
| 营业利润率 | 3.1% | 14.5% |
| 净利率 | 2.3% | 12.7% |
| 营收同比 | -0.9% | 5.9% |
| 净利润同比 | -67.6% | 3.9% |
| 每股收益（稀释后） | $0.44 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATKRRVTY
| Q4 25 | $655.5M | $772.1M | ||
| Q3 25 | $752.0M | $698.9M | ||
| Q2 25 | $735.0M | $720.3M | ||
| Q1 25 | $701.7M | $664.8M | ||
| Q4 24 | $661.6M | $729.4M | ||
| Q3 24 | $788.3M | $684.0M | ||
| Q2 24 | $822.4M | $691.7M | ||
| Q1 24 | $792.9M | $649.9M |
净利润ATKRRVTY
| Q4 25 | $15.0M | $98.4M | ||
| Q3 25 | $-54.4M | $46.7M | ||
| Q2 25 | $43.0M | $53.9M | ||
| Q1 25 | $-50.1M | $42.2M | ||
| Q4 24 | $46.3M | $94.6M | ||
| Q3 24 | $73.1M | $94.4M | ||
| Q2 24 | $123.4M | $55.4M | ||
| Q1 24 | $138.0M | $26.0M |
毛利率ATKRRVTY
| Q4 25 | 19.2% | — | ||
| Q3 25 | 19.7% | 53.6% | ||
| Q2 25 | 23.4% | 54.5% | ||
| Q1 25 | 26.4% | 56.5% | ||
| Q4 24 | 25.9% | — | ||
| Q3 24 | 27.4% | 56.3% | ||
| Q2 24 | 34.0% | 55.7% | ||
| Q1 24 | 36.8% | 54.6% |
营业利润率ATKRRVTY
| Q4 25 | 3.1% | 14.5% | ||
| Q3 25 | -7.5% | 11.7% | ||
| Q2 25 | 8.7% | 12.6% | ||
| Q1 25 | -7.4% | 10.9% | ||
| Q4 24 | 10.3% | 16.3% | ||
| Q3 24 | 12.9% | 14.3% | ||
| Q2 24 | 20.5% | 12.4% | ||
| Q1 24 | 22.6% | 6.8% |
净利率ATKRRVTY
| Q4 25 | 2.3% | 12.7% | ||
| Q3 25 | -7.2% | 6.7% | ||
| Q2 25 | 5.8% | 7.5% | ||
| Q1 25 | -7.1% | 6.4% | ||
| Q4 24 | 7.0% | 13.0% | ||
| Q3 24 | 9.3% | 13.8% | ||
| Q2 24 | 15.0% | 8.0% | ||
| Q1 24 | 17.4% | 4.0% |
每股收益（稀释后）ATKRRVTY
| Q4 25 | $0.44 | $0.86 | ||
| Q3 25 | $-1.55 | $0.40 | ||
| Q2 25 | $1.25 | $0.46 | ||
| Q1 25 | $-1.46 | $0.35 | ||
| Q4 24 | $1.31 | $0.77 | ||
| Q3 24 | $2.08 | $0.77 | ||
| Q2 24 | $3.33 | $0.45 | ||
| Q1 24 | $3.67 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $443.8M | $919.9M |
| 总债务越低越好 | $761.1M | — |
| 股东权益账面价值 | $1.4B | $7.3B |
| 总资产 | $2.8B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.54× | — |
8季度趋势，按日历期对齐
现金及短期投资ATKRRVTY
| Q4 25 | $443.8M | $919.9M | ||
| Q3 25 | $506.7M | $931.4M | ||
| Q2 25 | $331.0M | $991.8M | ||
| Q1 25 | $330.4M | $1.1B | ||
| Q4 24 | $310.4M | $1.2B | ||
| Q3 24 | $351.4M | $1.2B | ||
| Q2 24 | $303.7M | $2.0B | ||
| Q1 24 | $368.1M | $1.7B |
总债务ATKRRVTY
| Q4 25 | $761.1M | — | ||
| Q3 25 | $760.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $764.8M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ATKRRVTY
| Q4 25 | $1.4B | $7.3B | ||
| Q3 25 | $1.4B | $7.4B | ||
| Q2 25 | $1.5B | $7.6B | ||
| Q1 25 | $1.4B | $7.6B | ||
| Q4 24 | $1.5B | $7.7B | ||
| Q3 24 | $1.5B | $7.9B | ||
| Q2 24 | $1.6B | $7.9B | ||
| Q1 24 | $1.6B | $7.8B |
总资产ATKRRVTY
| Q4 25 | $2.8B | $12.2B | ||
| Q3 25 | $2.9B | $12.1B | ||
| Q2 25 | $2.9B | $12.4B | ||
| Q1 25 | $2.9B | $12.4B | ||
| Q4 24 | $3.0B | $12.4B | ||
| Q3 24 | $3.0B | $12.8B | ||
| Q2 24 | $3.0B | $13.4B | ||
| Q1 24 | $3.0B | $13.4B |
负债/权益比ATKRRVTY
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.54× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-55.5M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $-67.3M | $161.8M |
| 自由现金流率自由现金流/营收 | -10.3% | 21.0% |
| 资本支出强度资本支出/营收 | 1.8% | 2.6% |
| 现金转化率经营现金流/净利润 | -3.69× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $195.3M | $509.4M |
8季度趋势，按日历期对齐
经营现金流ATKRRVTY
| Q4 25 | $-55.5M | $182.0M | ||
| Q3 25 | $210.4M | $138.5M | ||
| Q2 25 | $31.4M | $134.3M | ||
| Q1 25 | $86.6M | $128.2M | ||
| Q4 24 | $74.4M | $174.2M | ||
| Q3 24 | $199.1M | $147.9M | ||
| Q2 24 | $104.6M | $158.6M | ||
| Q1 24 | $87.2M | $147.6M |
自由现金流ATKRRVTY
| Q4 25 | $-67.3M | $161.8M | ||
| Q3 25 | $188.2M | $120.0M | ||
| Q2 25 | $10.1M | $115.5M | ||
| Q1 25 | $64.2M | $112.2M | ||
| Q4 24 | $33.1M | $149.8M | ||
| Q3 24 | $154.3M | $125.6M | ||
| Q2 24 | $73.1M | $136.6M | ||
| Q1 24 | $58.0M | $129.7M |
自由现金流率ATKRRVTY
| Q4 25 | -10.3% | 21.0% | ||
| Q3 25 | 25.0% | 17.2% | ||
| Q2 25 | 1.4% | 16.0% | ||
| Q1 25 | 9.2% | 16.9% | ||
| Q4 24 | 5.0% | 20.5% | ||
| Q3 24 | 19.6% | 18.4% | ||
| Q2 24 | 8.9% | 19.7% | ||
| Q1 24 | 7.3% | 20.0% |
资本支出强度ATKRRVTY
| Q4 25 | 1.8% | 2.6% | ||
| Q3 25 | 3.0% | 2.6% | ||
| Q2 25 | 2.9% | 2.6% | ||
| Q1 25 | 3.2% | 2.4% | ||
| Q4 24 | 6.2% | 3.4% | ||
| Q3 24 | 5.7% | 3.3% | ||
| Q2 24 | 3.8% | 3.2% | ||
| Q1 24 | 3.7% | 2.7% |
现金转化率ATKRRVTY
| Q4 25 | -3.69× | 1.85× | ||
| Q3 25 | — | 2.97× | ||
| Q2 25 | 0.73× | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | 1.61× | 1.84× | ||
| Q3 24 | 2.72× | 1.57× | ||
| Q2 24 | 0.85× | 2.87× | ||
| Q1 24 | 0.63× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATKR
| Plastic Pipe And Conduit | $138.1M | 21% |
| Other Safety Infrastructure Products | $120.6M | 18% |
| Metal Electrical Conduit And Fittings | $118.4M | 18% |
| Electrical Cable And Flexible Conduit | $110.9M | 17% |
| Other Electrical Products | $102.2M | 16% |
| Mechanical Pipe | $65.4M | 10% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
